Linkedin
SCIRENT: Advancing cardiovascular research for a healthier tomorrow
Get in touch
BLOG 

Cardiovascular Clinical Research

Discover the latest updates on cardiovascular clinical research, innovative studies, and exciting conference news. Join us on our journey as we explore the latest discoveries and innovations transforming how we understand and treat cardiovascular diseases.

  • All
  • Careers
  • Conferences
  • Insights
  • Press release
Press release

Prof. Dr. Wilhelm Haverkamp Appointed Chief Medical Officer at SCIRENT

Wiebke Lesch 16. April 2026
Berlin, 16. April 2026. SCIRENT announced the appointment of Prof. Dr. Wilhelm Haverkamp as Chief Medical Officer (CMO), effective immediately. In this role, Prof. Haverkamp will further strengthen SCIRENT’s medical and scientific leadership and expand the company’s activities in drug...
CSI Focus D-HF
Conferences

SCIRENT to Participate in CSI Focus D-HF 2025 in Frankfurt

Wiebke Lesch 26. November 2025
SCIRENT, a full-service cardiovascular Contract Research Organization (CRO) specializing in clinical studies for heart failure and cardiac devices, will participate in the upcoming CSI Focus D-HF 2025, taking place December 5–6, 2025, in Frankfurt, Germany. The conference is the leading...
Prof. Dr. Thomas Bernd Dschietzig, CEO of Relaxera, and Prof. Dr. Hans-Dirk Düngen, CEO of SCIRENT, at the SCIRENT booth during ESC 2025 in Madrid. The two experts discuss the SOURCE-HF phase 2 clinical trial investigating relaxin-2 in heart failure.
Conferences

SOURCE-HF Phase 2 Study – collaboration announcement between Relaxera and Scirent

Angelika Gaufer 1. September 2025
A behind-the-scenes look at ESC 2025 in Madrid At this year’s European Society of Cardiology (ESC) Congress in Madrid, the spotlight was not only on cutting-edge research and innovation in cardiovascular medicine. One of the highlights at the SCIRENT booth was a video...
SCIRENT booth at ESC Heart Failure 2025 in Belgrade with people networking, seated discussions, and clinical research banners in the background.
Conferences

ESC Heart Failure 2025 – A Very Special Congress for SCIRENT in Belgrade

Angelika Gaufer 22. May 2025
The ESC Heart Failure Congress in Belgrade this year was a truly special event for all of us at SCIRENT. Not only because it is one of the most important international gatherings in our field, but also because it was...
SCIRENT invites you to ACC.25 in Chicago, showcasing their expertise in cardiovascular trials and partnerships in biopharma and medtech.
Conferences

SCIRENT is heading to ACC.25 in Chicago!

Wiebke Lesch 25. March 2025
We’re excited to announce that SCIRENT, a leading Contract Research Organization (CRO) specializing in cardiovascular research, will be attending the American College of Cardiology's Annual Scientific SessionACC.25, taking place from March 29–31, 2025 at McCormick Place, Chicago, IL. With over 300 sessions, groundbreaking research presentations, and unparalleled networking...
Portrait of Angelika Gaufer, a marketing executive at SCIRENT, speaking during an interview.
Careers

From Big Pharma to specialized CRO – A Conversation on International Women’s Day

Goran Ebersold 8. March 2025
It's early March, and as spring begins, we celebrate a special day that is even a public holiday in Berlin: International Women's Day. This day not only reminds us of women's achievements and rights but also of how important their...
A man balancing on a tightrope stretched between two hourglasses, symbolizing the delicate balance of time in clinical research.
Insights

Success Through Punctuality: How Adhering to Timelines Secures Funding for Clinical Trials

Goran Ebersold 20. February 2025
In clinical research, milestones like study initiation, patient recruitment, or the completion of data analysis are closely tied to investor payments. Funding for the next phase is only released once a milestone is achieved. This structure provides clarity but also...
Logo of the THT Conference 2025 in Boston, featuring the event's name and stylized heart graphic. Below the logo, text displays the conference dates, February 11-13, 2025, and location details. The background is clean and professional with a medical and scientific theme, emphasizing the focus on cardiovascular research and therapy advancements
Conferences

SCIRENT at THT 2025 in Boston: Commitment and Expertise in Cardiovascular Research

Wiebke Lesch 4. February 2025
As a leading Contract Research Organization specializing in cardiovascular research, SCIRENT is eager to join the THT Conference in Boston from February 11-13, 2025. This conference is a crucial hub for professionals to exchange information about advanced therapies and technologies. We take pride...
A senior female researcher, focused and diligent, writes notes while analyzing data in a modern laboratory environment. She is part of a team dedicated to developing innovative treatments aimed at improving patient outcomes worldwide. The image highlights her concentration and expertise in the field of clinical research.
Insights

Milestones Achieved: PEI Approval and First Participant Dosed in TGD001 Phase 1 Study

Goran Ebersold 22. January 2025
At SCIRENT, we are excited to work for TargED Biopharmaceuticals B.V. in developing TGD001, an innovative thrombolytic therapy for thrombotic diseases.  PEI Approval in Record Time In October 2024, TargED Biopharmaceuticals B.V. received approval from the Paul-Ehrlich-Institut (PEI) for a...
Logo for the ESC Congress 2024 in London, featuring colorful circuit-like paths forming a heart shape
Conferences

SCIRENT at ESC Congress 2024: Pioneering Cardiovascular Research

Goran Ebersold 12. July 2024
Date: Friday, August 30 - Monday, September 2, 2024 Location: London, United Kingdom We are thrilled to announce that SCIRENT, a leading European cardiovascular clinical research organization, will be participating in this year's ESC Congress 2024 in London. Visit us...
Oxford University historic buildings and bicycles
Insights

Celebrating Success: Imbria Pharmaceuticals’ Phase 2 IMPROVE-HCM Trial Results

Goran Ebersold 8. June 2024
We are thrilled to convey our heartfelt congratulations to Imbria Pharmaceuticals on the outstanding results from the Phase 2 IMPROVE-HCM clinical trial. The trial, which evaluated ninerafaxstat in patients with symptomatic non-obstructive hypertrophic cardiomyopathy (nHCM), has shown significant improvements in...
A healthcare professional performing an echocardiography examination on a male patient, showcasing the ultrasound probe in use on the patient's chest with the echocardiogram display in the background.
Insights

Echo Core Lab is a Key for Using Echocardiography in Clinical Trials

Aravindkumar Radhakrishnan 29. May 2024
Echocardiography is a noninvasive method to assess cardiac anatomy, function, and hemodynamics and may provide important data on the effects of a new drug or medical device. In many cardiovascular clinical trials, echocardiography data are used for assessing eligibility and...
A healthcare professional interacts with digital healthcare and finance icons, symbolizing the integration and transition in healthcare management.
Insights

Navigating Change: Navigating a CRO Transition in Cardiovascular Research

Goran Ebersold 3. April 2024
The ability to steer through changes and skillfully manage a transition to another Contract Research Organization (CRO) is sometimes essential for progress in the dynamic field of cardiovascular research. CROs are indispensable; they accelerate the translation of innovative cardiovascular therapies...
Comprehensive Approach to Phase 1 Cardiovascular Studies
Insights

Integrating Phase 1 Studies in Healthy Volunteers and Patients with Cardiovascular Disease – A Comprehensive Approach  

Maximilian Posch 19. February 2024
Phase 1 clinical studies are the initial step in drug development, designed to assess the safety and tolerability of a new molecule in humans. Traditionally investigational medicinal products (IMP) were tested in multiple Phase 1 clinical trials that enrolled large...
Single researcher analyzing cardiovascular research data on a large monitor in a professional office setting, showing deep concentration and note-taking.
Insights

Site Management and Study Start-Up Enhancement: A Strategic Focus in Cardiovascular Research

Goran Ebersold 30. January 2024
Insights into best practices and efficiency improvement in clinical trials highlight the importance of thorough site identification and selection in the field of cardiovascular research. Managing the complex regulatory environment requires well-thought-out document management and early engagement with regulatory authorities....
A detailed overview of cardiovascular clinical trials showcasing the strategic importance of partnering with specialist CROs for enhanced trial efficiency and success.
Insights

Maximizing Success in Cardiovascular Trials: The Advantage of Partnering with a Specialist CRO

Maximilian Posch 17. January 2024
The industry spent over $200 billion globally in 2021 on developing new therapies for treating cardiovascular diseases. However, it’s estimated that more than half of the investment in clinical development is wasted. Various factors contribute to this, including a lack...
A Clinical Research Associate monitoring data on a laptop with cardiovascular charts and medical equipment in the background, symbolizing a cardiovascular trial in Europe.
Careers

What is a Clinical Research Associate doing?

Goran Ebersold 19. December 2023
Maike, 32, and Nadja, 32, work as Clinical Research Associates (CRA) in medical research. They discuss what makes this job unique and why they enjoy working as CRAs. Maike, how did your day start today? Maike: I returned from Oslo...
Conferences

SCIRENT is excited to participate at the TCT Conference 2023 in San Francisco

Wiebke Lesch 11. October 2023
SCIRENT is excited to participate at the TCT Conference from October 23-26, 2023, in San Francisco. The Transcatheter Cardiovascular Therapeutics (TCT) conference, hosted by the Cardiovascular Research Foundation (CRF), is the world's premier educational forum for interventional cardiovascular medicine. For...
heart surgery
Insights

First patient enrolled in feasibility trial for JuxtaFlow® Renal Assist Device (RAD)

Wiebke Lesch 11. October 2023
Roswell, Georgia – 9 October, 2023 – Roivios Ltd., a medical device company pioneering a revolutionary treatment to reduce poor surgical outcomes associated with Acute Kidney Injury (AKI), today announces the first patient has been enrolled in the BIPASS-AKI early...
Come and be a part of Amsterdam ESC 2023, where you can witness groundbreaking developments in cardiovascular treatment. Collaborate with the most prominent professionals in the industry, delve into state-of-the-art abstracts, and unleash innovative possibilities for your patients. This is an unmissable chance to forge connections with Europe's leading cardiovascular CRO as well - let us work together towards achieving better health outcomes!
Conferences

Join SCIRENT at ESC Congress 2023

Wiebke Lesch 12. July 2023
SCIRENT will be participating in the renowned ESC Congress in Amsterdam from 25th to 28th August 2023. This prestigious event is a powerful platform for us as it brings together leading experts from the field of cardiology to shape the...
Showing Slide 1 of 21
Load More
SCIRENT invites you to ACC.25 in Chicago, showcasing their expertise in cardiovascular trials and partnerships in biopharma and medtech.

SCIRENT is heading to ACC.25 in Chicago!

Wiebke Lesch 25. March 2025

We’re excited to announce that SCIRENT, a leading Contract Research Organization (CRO) specializing in cardiovascular research, will be attending the American College of Cardiology’s Annual Scientific SessionACC.25, taking place

Weiterlesen »
Book a meeting

Thank you for your application.

We will get in touch shortly.

Thank you. Your data was submitted successfully.

We will get in touch shortly.